Canadian Organization for Rare Disorders

Representing the Canadian Organization for Rare Disorders (CORD), as an intervenor before the Supreme Court of Canada in an appeal brought by Pharmascience Inc. regarding whether methods of medical treatment constitute patentable subject matter, and the patentability of novel dosage regimens.